ES2075415T3 - Nuevo inhibidor de agregacion de plaquetas. - Google Patents

Nuevo inhibidor de agregacion de plaquetas.

Info

Publication number
ES2075415T3
ES2075415T3 ES91870098T ES91870098T ES2075415T3 ES 2075415 T3 ES2075415 T3 ES 2075415T3 ES 91870098 T ES91870098 T ES 91870098T ES 91870098 T ES91870098 T ES 91870098T ES 2075415 T3 ES2075415 T3 ES 2075415T3
Authority
ES
Spain
Prior art keywords
platelet aggregation
aggregation inhibitor
new platelet
new
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91870098T
Other languages
English (en)
Inventor
Foe Siong Tjoeng
Steven Paul Adams
Larry Philip Feigen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
GD Searle LLC
Original Assignee
Monsanto Co
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co, GD Searle LLC filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2075415T3 publication Critical patent/ES2075415T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE DESCRIBE N-[8-[(AMINOIMINOMETIL)AMINO]-1-OXOOCTIL]-N-L-(ALFA)ASPARTIL-L-FENILALANINA COMO UN INHIBIDOR MUY POTENTE DE AGREGACION DE PLAQUETAS.
ES91870098T 1990-06-20 1991-06-19 Nuevo inhibidor de agregacion de plaquetas. Expired - Lifetime ES2075415T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,953 US5053393A (en) 1988-07-20 1990-06-20 Novel platelet-aggregation inhibitor

Publications (1)

Publication Number Publication Date
ES2075415T3 true ES2075415T3 (es) 1995-10-01

Family

ID=24157584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91870098T Expired - Lifetime ES2075415T3 (es) 1990-06-20 1991-06-19 Nuevo inhibidor de agregacion de plaquetas.

Country Status (17)

Country Link
US (1) US5053393A (es)
EP (1) EP0462960B1 (es)
JP (1) JPH0651719B2 (es)
KR (1) KR940000753B1 (es)
AT (1) ATE123293T1 (es)
AU (1) AU631070B2 (es)
CA (1) CA2044978C (es)
DE (1) DE69110091T2 (es)
DK (1) DK0462960T3 (es)
ES (1) ES2075415T3 (es)
FI (1) FI106380B (es)
IE (1) IE72519B1 (es)
IL (1) IL98557A (es)
NO (1) NO301373B1 (es)
NZ (1) NZ238611A (es)
PT (1) PT98026B (es)
ZA (1) ZA914728B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
TW201303B (es) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5260277A (en) * 1990-09-10 1993-11-09 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
US5625093A (en) * 1991-10-15 1997-04-29 G. D. Searle & Co. Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
US5254573A (en) * 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
WO1993008823A1 (en) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5258398A (en) * 1991-12-16 1993-11-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic diaminoalkanoic acid derivatives
TW223629B (es) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
US6380163B1 (en) * 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
DE4302485A1 (de) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
AU687790B2 (en) * 1993-02-09 1998-03-05 Biogen Idec Ma Inc. Treatment for insulin dependent diabetes
EP0623615B1 (de) * 1993-05-01 1999-06-30 MERCK PATENT GmbH Substituierte 1-Phenyl-oxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als Adhäsionsrezeptor-Antagonisten
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DE4405378A1 (de) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ES2123889T3 (es) 1994-11-02 1999-01-16 Merck Patent Gmbh Antagonistas de receptores de adhesion.
DE4439846A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5872122A (en) * 1997-10-16 1999-02-16 Monsanto Company Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (es) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
US4127580A (en) * 1975-02-07 1978-11-28 Parcor Process for the preparation of thieno-pyridine derivatives
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5169836A (en) * 1988-11-10 1992-12-08 Trustees Of The University Of Penna. Inhibitors of platelet binding
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives

Also Published As

Publication number Publication date
NZ238611A (en) 1992-09-25
DK0462960T3 (da) 1995-10-02
US5053393A (en) 1991-10-01
FI913006A0 (fi) 1991-06-19
DE69110091D1 (de) 1995-07-06
KR920000785A (ko) 1992-01-29
NO912396L (no) 1991-12-23
IL98557A (en) 1996-01-31
DE69110091T2 (de) 1996-02-08
IL98557A0 (en) 1992-07-15
AU7912191A (en) 1992-01-02
AU631070B2 (en) 1992-11-12
IE72519B1 (en) 1997-04-23
NO301373B1 (no) 1997-10-20
ATE123293T1 (de) 1995-06-15
IE912100A1 (en) 1992-01-01
NO912396D0 (no) 1991-06-19
KR940000753B1 (ko) 1994-01-29
EP0462960A1 (en) 1991-12-27
PT98026B (pt) 1998-11-30
FI106380B (fi) 2001-01-31
PT98026A (pt) 1992-04-30
CA2044978C (en) 2001-06-12
JPH04230299A (ja) 1992-08-19
FI913006A (fi) 1991-12-21
JPH0651719B2 (ja) 1994-07-06
ZA914728B (en) 1993-02-24
EP0462960B1 (en) 1995-05-31
CA2044978A1 (en) 1991-12-21

Similar Documents

Publication Publication Date Title
ES2075415T3 (es) Nuevo inhibidor de agregacion de plaquetas.
LV10622A (lv) Savienojumi ar diviem kondensetiem ciklien un panemiens to iegusanai
HU9401020D0 (en) Cyclic ureas and analogues
SE8600413D0 (sv) Nytt lekemedel och sett att framstella detsamma
DE69033069D1 (de) Prostaglandinanaloge
DK0398283T3 (da) Stimulatoriske aminosyreantagonister
DK397989D0 (da) Peptidderivater og laegemidler mod demens med indhold af saadanne forbindelser
NO903927L (no) N-azabicyklo(3.3.0)oktan-amider av aromatiske syrer.
DE69011702D1 (de) Derivate von Aminocarboxylsäure.
ES8205221A1 (es) Procedimiento para la preparacion de una sulfonamida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462960

Country of ref document: ES